EastGate is a pharmaceutical company.  We focus on alternative drug delivery of products that are currently delivered by injection.   Our first development is a liquid insulin mouth rinse for Type 2 diabetes patients.   Our goal is to introduce insulin (which is the best diabetes treatment for diabetes patients) to Type 2 patients early in their treatment paradigm rather than as a last resort. Our liquid insulin mouth rinse will not only improve the quality of life for diabetes patients but decrease the financial burden on the government and healthcare institutions around the world. Forward thinking investors that understand the insulin marketplace, should add this undervalued token to their portfolio. We are committed to increasing value for all wallet holders. Our plans in Web3:- (1) To create a distributed platform for Healthcare centers across the globe using EGP as the native token (2) To market our other OTC products through the Blockchain as per our plan that you can find in the Whitepaper (3) To provide an opportunity for investors to own a percentage of our achievements in technology